|Mr. Michael C. Boyd||Chairman and Chief Exec. Officer||N/A||N/A||75|
|Mr. Paul D. Wilson||Pres, Chief Financial Officer, Director and Managing Director of Longport International - UK||126.82k||N/A||59|
|Mr. John P. Calabrese||Director of Sales and Marketing||N/A||N/A||N/A|
Longport, Inc. develops, manufactures, markets, and sells high resolution . primarily in the United States. It offers EPISCAN I-200, a high frequency ultrasound imaging system that utilizes ultrasound at frequencies between 20 and 50MHz to image the skin and underlying soft tissue. The companys products are used in wound assessment, wound prevention, clinical dermatology, and aesthetics/plastics, as well as in various other applications, including burn assessment, superficial musculoskeletal imaging, and veterinary applications. It also exports its products. The company was founded in 1993 and is based in Chadds Ford, Pennsylvania.
Longport Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.